Compare BIO & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | REXR |
|---|---|---|
| Founded | 1952 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.4B |
| IPO Year | N/A | 2013 |
| Metric | BIO | REXR |
|---|---|---|
| Price | $298.85 | $38.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | ★ $358.50 | $43.22 |
| AVG Volume (30 Days) | 232.0K | ★ 2.3M |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 4.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $2,557,500,000.00 | $1,003,133,000.00 |
| Revenue This Year | $1.50 | $2.58 |
| Revenue Next Year | $2.23 | $4.08 |
| P/E Ratio | ★ N/A | $45.02 |
| Revenue Growth | N/A | ★ 7.13 |
| 52 Week Low | $211.43 | $29.68 |
| 52 Week High | $351.02 | $44.38 |
| Indicator | BIO | REXR |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 42.94 |
| Support Level | $298.09 | $38.69 |
| Resistance Level | $307.41 | $41.60 |
| Average True Range (ATR) | 8.89 | 0.88 |
| MACD | -0.23 | -0.04 |
| Stochastic Oscillator | 49.88 | 7.39 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.